Clinical Trials Logo

Clinical Trial Summary

This study aim to investigate Changes in tumor tissue and serum biomarkers before and after cetuximab combined with preoperative radiotherapy in locally advanced thoracic middle-lower segment esophageal squamous cell carcinoma.We want to find one or more effective biomarkers to predict and evaluate the patients who will be benefit from cetuximab combined with preoperative radiotherapy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02123381
Study type Interventional
Source Sichuan Cancer Hospital and Research Institute
Contact TAO LI, MD, PhD
Phone 86-18908178818
Email litaoxmf@126.com
Status Recruiting
Phase Phase 2
Start date April 2014
Completion date July 2020